SG11202009338SA - Modulators of g-protein coupled receptors - Google Patents

Modulators of g-protein coupled receptors

Info

Publication number
SG11202009338SA
SG11202009338SA SG11202009338SA SG11202009338SA SG11202009338SA SG 11202009338S A SG11202009338S A SG 11202009338SA SG 11202009338S A SG11202009338S A SG 11202009338SA SG 11202009338S A SG11202009338S A SG 11202009338SA SG 11202009338S A SG11202009338S A SG 11202009338SA
Authority
SG
Singapore
Prior art keywords
modulators
protein coupled
coupled receptors
receptors
protein
Prior art date
Application number
SG11202009338SA
Other languages
English (en)
Inventor
Johan Enquist
Shyam Krishnan
Suman Atwal
Daniel Erlanson
Raymond V Fucini
Stig Hansen
Andrew Sawayama
Steven Sethofer
Original Assignee
Carmot Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carmot Therapeutics Inc filed Critical Carmot Therapeutics Inc
Publication of SG11202009338SA publication Critical patent/SG11202009338SA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11202009338SA 2018-03-23 2019-03-22 Modulators of g-protein coupled receptors SG11202009338SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862647604P 2018-03-23 2018-03-23
PCT/US2019/023726 WO2019183577A1 (fr) 2018-03-23 2019-03-22 Modulateurs de récepteurs couplés à la protéine

Publications (1)

Publication Number Publication Date
SG11202009338SA true SG11202009338SA (en) 2020-10-29

Family

ID=67986596

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202009338SA SG11202009338SA (en) 2018-03-23 2019-03-22 Modulators of g-protein coupled receptors

Country Status (15)

Country Link
US (2) US11535660B1 (fr)
EP (1) EP3768294A4 (fr)
JP (1) JP2021531259A (fr)
KR (1) KR20210008834A (fr)
CN (1) CN112236161A (fr)
AR (1) AR115016A1 (fr)
AU (1) AU2019237507A1 (fr)
BR (1) BR112020019148A2 (fr)
CA (1) CA3094820A1 (fr)
EA (1) EA202092269A1 (fr)
IL (2) IL311177A (fr)
MX (1) MX2020009950A (fr)
PH (1) PH12020551539A1 (fr)
SG (1) SG11202009338SA (fr)
WO (1) WO2019183577A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022272251A1 (en) * 2021-05-13 2023-11-16 Carmot Therapeutics Inc. Modulators of g-protein coupled receptors
KR20230062994A (ko) 2021-11-01 2023-05-09 국민대학교산학협력단 글루카곤 유사 펩타이드-1 수용체의 양성 알로스테릭 조절제의 스크리닝 방법 및 그 방법에 따라 스크리닝된 글루카곤 유사 펩타이드-1 수용체의 양성 알로스테릭 조절제
WO2024033374A1 (fr) 2022-08-11 2024-02-15 Syngenta Crop Protection Ag Nouveaux composés arylcarboxamide ou arylthioamide
WO2024089216A1 (fr) 2022-10-27 2024-05-02 Syngenta Crop Protection Ag Nouveaux composés hétéroaryl-carboxamides contenant du soufre

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997010224A1 (fr) 1995-09-13 1997-03-20 Takeda Chemical Industries, Ltd. Composes de benzoxazepine, leur production et leur utilisation en tant qu'agent d'abaissement des niveaux de lipides
US6432947B1 (en) 1997-02-19 2002-08-13 Berlex Laboratories, Inc. N-heterocyclic derivatives as NOS inhibitors
JP2002506792A (ja) * 1998-02-27 2002-03-05 ノボ ノルディスク アクティーゼルスカブ Ｎ末端修飾ｇｌｐ−１誘導体
PL202367B1 (pl) * 1998-12-07 2009-06-30 Sod Conseils Rech Applic Związki stanowiące analogi GLP-1, kompozycje zawierające te związki oraz zastosowanie tych związków
WO2001062765A2 (fr) 1999-02-26 2001-08-30 Arena Pharmaceuticals, Inc. Modulateurs a petites molecules du recepteur six couple a la proteine g
JP2003508501A (ja) 1999-09-07 2003-03-04 コンジュケム，インコーポレーテッド 生物学的結合のための肺送達
US20030187023A1 (en) 2000-07-17 2003-10-02 Keiji Kubo Sulfone derivatives, process for their production and use thereof
BR0315815A (pt) 2002-11-01 2005-09-13 Takeda Pharmaceutical Agentes para prevenir ou tratar neuropatia, para promover a produção ou a secreção de um fator neurotrópico, para melhorar a dor, neuroprotetor e farmacêutico, composto, métodos para prevenir ou tratar neuropatia e para promover a produção ou a secreção de um fator neurotrópico, para melhorar a dor para proteger um nervo em um mamìfero e para produzir um composto e uso de um composto
EP2385032A1 (fr) 2002-11-08 2011-11-09 Takeda Pharmaceutical Company Limited Régulateur de fonction de récepteur GPR40
EP1564213A4 (fr) 2002-11-22 2009-05-27 Takeda Pharmaceutical Derives d'imidazole, leur procede de production et d'utilisation
US20050059605A1 (en) 2003-01-31 2005-03-17 Krishna Peri Chemically modified metabolites of regulatory peptides and methods of producing and using same
EP1630152A4 (fr) 2003-05-30 2009-09-23 Takeda Pharmaceutical Compose cyclique condense
EP2932981B1 (fr) * 2003-09-19 2021-06-16 Novo Nordisk A/S Dérivés du GLP-1 se liant à l'albumine
WO2005030740A1 (fr) 2003-09-30 2005-04-07 Takeda Pharmaceutical Company Limited Derive thiazoline et utilisation
EP1695961A4 (fr) 2003-12-17 2007-10-24 Takeda Pharmaceutical Derives d'uree, processus de production correspondant et utilisation
TW200523247A (en) 2003-12-25 2005-07-16 Takeda Pharmaceutical 3-(4-benzyloxyphenyl) propanoic acid derivatives
WO2005063725A1 (fr) 2003-12-26 2005-07-14 Takeda Pharmaceutical Company Limited Derives d'acide phenylpropanoique
US7786165B2 (en) 2004-03-15 2010-08-31 Takeda Pharmaceutical Company Limited Aminophenylpropanoic acid derivative
EP2253315A1 (fr) 2004-03-30 2010-11-24 Takeda Pharmaceutical Company Limited Dérivés d'acide alkoxypropanoique
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
US20060275288A1 (en) 2005-01-20 2006-12-07 Grihalde Nelson D GLP-1 receptor agonist and allosteric modulator monoclonal antibodies and uses thereof
JP5094394B2 (ja) 2005-04-20 2012-12-12 武田薬品工業株式会社 縮合複素環化合物
JP2008539735A (ja) * 2005-05-06 2008-11-20 バイエル・フアーマシユーチカルズ・コーポレーシヨン グルカゴン様ペプチド１（ｇｌｐ−１）受容体アンタゴニストおよびそれらの薬理学的使用方法
EP1911738A4 (fr) 2005-07-29 2009-12-16 Takeda Pharmaceutical Composé de l acide phénoxyalkanoique
JP5084503B2 (ja) 2005-07-29 2012-11-28 武田薬品工業株式会社 シクロプロパンカルボン酸化合物
MX2008001386A (es) 2005-08-10 2008-04-07 Takeda Pharmaceutical Agente terapeutico para diabetes.
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
CN101420941A (zh) * 2006-04-11 2009-04-29 艾尼纳制药公司 Gpr119受体激动剂用于增加骨质量和用于治疗骨质疏松症的用途,和其相关组合疗法
ME00535B (me) 2006-06-27 2011-10-10 Takeda Pharmaceuticals Co Fuzionisana ciklična jedinjenja
WO2008021560A2 (fr) * 2006-08-17 2008-02-21 Amylin Pharmaceuticals, Inc. Analogue du gip et polypeptides hybrides possédant des propriétés sélectives
EP2298772A1 (fr) 2006-10-18 2011-03-23 Takeda Pharmaceutical Company Limited Composés hétérocycliques condenseé
US8410087B2 (en) 2006-10-19 2013-04-02 Takeda Pharmaceutical Company Limited Indole compound
EP2128138A1 (fr) 2007-01-29 2009-12-02 Takeda Pharmaceutical Company Limited Composé de pyrazole
WO2008099794A1 (fr) 2007-02-09 2008-08-21 Takeda Pharmaceutical Company Limited Composés à cycles fusionnés utiles en tant qu'agonistes partiels de ppar-gamma
WO2008136428A1 (fr) 2007-04-27 2008-11-13 Takeda Pharmaceutical Company Limited Composé hétérocyclique à cinq chaînons à teneur en azote
WO2008156757A1 (fr) 2007-06-19 2008-12-24 Takeda Pharmaceutical Company Limited Composés d'indazole permettant d'activer la glucokinase
EA020326B9 (ru) * 2008-06-17 2015-03-31 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн Агонисты смешанного действия на основе глюкозозависимого инсулинотропного пептида для лечения нарушений обмена веществ и ожирения
TW201006821A (en) * 2008-07-16 2010-02-16 Bristol Myers Squibb Co Pyridone and pyridazone analogues as GPR119 modulators
US20120148586A1 (en) 2009-08-27 2012-06-14 Joyce Ching Tsu Chou Glucagon-like protein-1 receptor (glp-1r) agonists for treating autoimmune disorders
US8426414B2 (en) 2009-10-09 2013-04-23 Bristol-Myers Squibb Company Modulators of G protein-coupled receptor 88
KR20120123443A (ko) * 2010-01-27 2012-11-08 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 대사 장애 및 비만 치료용 글루카곤 길항제-ｇｉｐ 항진제 콘쥬게이트
US20120021979A1 (en) 2010-06-24 2012-01-26 Vanderbilt University GLP-1 receptor modulation of addiction, neuropsychiatric disorders and erectile dysfunction
WO2013148579A1 (fr) 2012-03-29 2013-10-03 Cebix Inc. C-peptide pégylé
CA2890190A1 (fr) * 2012-11-12 2014-05-15 Redwood Bioscience, Inc. Composes et procedes pour produire un conjugue
ES2748162T3 (es) * 2012-12-06 2020-03-13 Victoria Link Ltd Compuestos conjugados
US9766239B2 (en) 2013-03-13 2017-09-19 Arizona Board Of Regents On Behalf Of Arizona State University Synbodies for detection of human norovirus
JP6659535B2 (ja) * 2013-06-28 2020-03-04 オークランド ユニサービシーズ リミティド アミノ酸及びペプチド接合体及び接合方法
US10011649B2 (en) 2013-08-26 2018-07-03 Arizona Board Of Regents On Behalf Of Arizona State University High affinity synbodies for influenza
CA2967077A1 (fr) * 2014-11-14 2016-05-19 Angiochem Inc. Conjugues comprenant une partie anticorps, un polypeptide capable de traverser la barriere hemato-encephalique, et une cytokine
WO2016131893A1 (fr) 2015-02-18 2016-08-25 Medimmune Limited Polypeptides de fusion de l'incrétine
CN105219802A (zh) * 2015-10-10 2016-01-06 广西大学 胰岛组织特异性表达GIPRdn慢病毒载体及其应用
GB2551945B (en) * 2015-12-18 2021-09-08 Heptares Therapeutics Ltd Novel GLP-1 receptor agonist peptides

Also Published As

Publication number Publication date
US20230357347A1 (en) 2023-11-09
CA3094820A1 (fr) 2019-09-26
EP3768294A1 (fr) 2021-01-27
IL277495A (en) 2020-11-30
PH12020551539A1 (en) 2021-06-07
WO2019183577A1 (fr) 2019-09-26
JP2021531259A (ja) 2021-11-18
AR115016A1 (es) 2020-11-18
IL311177A (en) 2024-04-01
EA202092269A1 (ru) 2020-12-14
CN112236161A (zh) 2021-01-15
BR112020019148A2 (pt) 2021-01-26
IL277495B1 (en) 2024-04-01
MX2020009950A (es) 2021-04-28
EP3768294A4 (fr) 2022-05-04
US11535660B1 (en) 2022-12-27
AU2019237507A1 (en) 2020-10-08
TW202012432A (zh) 2020-04-01
KR20210008834A (ko) 2021-01-25

Similar Documents

Publication Publication Date Title
IL259342B (en) Modulators of chemokine receptors
IL277495A (en) Modulators of protein-coupled receptors - G
HK1253558A1 (zh) 法尼醇x受體調節劑
DK3433234T3 (da) Allosteriske modulatorer af nicotinacetylcholinreceptorer
IL280033A (en) Uses of anti-BCMA chimeric antigen receptors
IL281492A (en) Modulators of PNPLA3 expression
GB201717974D0 (en) Modified receptors
IL283967A (en) Modulators of hsd17b13 expression
IL274322A (en) Spirocyclic compounds as paranoid X receptor modulators
IL275139A (en) NKG2D DARIC receptors
IL278936A (en) Pyrimidine cyclophenyl glucocorticoid and mineralocorticoid receptor modulators
IL278045A (en) History of pyrazo-tetrahydroisoquinoline as a dopamine D1 receptor with positive modulators
PT3248964T (pt) Moduladores tiazólicos de recetores a3 de adenosina
DK3581572T3 (da) Adenosin-A3-receptormodulatorer
IL278740B1 (en) Methods for using splicing modulators
IL308392A (en) G protein-coupled receptor modulators
IL282364A (en) 5-HT4 receptor agonist uses
AU2015905333A0 (en) Modulators of Endosomal G Protein-Coupled Receptors
EP3177737A4 (fr) Nouveaux modulateurs des récepteurs de la mélanocortine